» Articles » PMID: 31111108

Validation and Stability Analysis of a Modified Lactate Dehydrogenase (LDH) Test Method to Be Employed for an Viable Skin Model

Overview
Journal Heliyon
Specialty Social Sciences
Date 2019 May 22
PMID 31111108
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

In view of increasing numbers of dermatological disorders, transdermal drug delivery along with research is becoming increasingly popular. Herefore, qualified skin models are required. The objective of this study was the optimization and validation of a modified lactate dehydrogenase (LDH) release assay during the establishment of an viable human skin model, employable for a variety of skin associated disorders. Firstly, the most suitable LDH isoform for the study was determined. Subsequently, a stability study was conducted to investigate the best storage conditions of the LDH enzyme. Finally, the test system was validated in terms of linear range, range limits and system suitability. The results indicate LDH-5 as most suitable isoform due to its predominance in skin. The stability samples stored at -20 °C in the presence of polyethylene glycol (PEG) as cryoprotector displayed the targeted recovery of 100% ± 15 % until the end of the four-week study in contrast to other investigated conditions. A six-point calibration without PEG and a seven-point calibration with PEG including evaluation of system suitability and quantification limits were established with both correlation coefficients r above 0.99 and all deviations below 15%. Concluding from those results, this method can be considered valid and useful for its employment in viability determination of viable skin models.

Citing Articles

Lactate dehydrogenase activity staining demonstrates time-dependent immune cell infiltration in human ex-vivo burn-injured skin.

Cuddihy J, Wu G, Ho L, Kudo H, Dannhorn A, Mandalia S Sci Rep. 2021; 11(1):21249.

PMID: 34711882 PMC: 8553775. DOI: 10.1038/s41598-021-00644-5.


The Oral Administration of Extract Improves Physical Performance through LDHA Modulation.

Han J, Kim M, Choi H, Jin J, Lee S, Bae S Molecules. 2021; 26(6).

PMID: 33809377 PMC: 7998416. DOI: 10.3390/molecules26061579.


Bioengineered Skin Intended as In Vitro Model for Pharmacosmetics, Skin Disease Study and Environmental Skin Impact Analysis.

Sanabria-de la Torre R, Fernandez-Gonzalez A, Quinones-Vico M, Montero-Vilchez T, Arias-Santiago S Biomedicines. 2020; 8(11).

PMID: 33142704 PMC: 7694072. DOI: 10.3390/biomedicines8110464.


Establishment of an model of cultured viable human, porcine and canine skin and comparison of different media supplements.

Bauhammer I, Sacha M, Haltner E PeerJ. 2019; 7:e7811.

PMID: 31592353 PMC: 6778665. DOI: 10.7717/peerj.7811.

References
1.
LEWIS Jr C, Schmitt M, Hershey F . Heterogeneity of lactic dehydrogenase of human skin. J Invest Dermatol. 1967; 48(3):221-5. DOI: 10.1038/jid.1967.34. View

2.
Kao J, Patterson F, Hall J . Skin penetration and metabolism of topically applied chemicals in six mammalian species, including man: an in vitro study with benzo[a]pyrene and testosterone. Toxicol Appl Pharmacol. 1985; 81(3 Pt 1):502-16. DOI: 10.1016/0041-008x(85)90421-1. View

3.
Bopp S, Lettieri T . Comparison of four different colorimetric and fluorometric cytotoxicity assays in a zebrafish liver cell line. BMC Pharmacol. 2008; 8:8. PMC: 2438350. DOI: 10.1186/1471-2210-8-8. View

4.
Tsang V, Bhatia S . Three-dimensional tissue fabrication. Adv Drug Deliv Rev. 2004; 56(11):1635-47. DOI: 10.1016/j.addr.2004.05.001. View

5.
Akhtar A . The flaws and human harms of animal experimentation. Camb Q Healthc Ethics. 2015; 24(4):407-19. PMC: 4594046. DOI: 10.1017/S0963180115000079. View